Mandate

Anhui Shanying Paper acquires Nordic Paper

August 02, 2017

Vinge has advised Anhui Shanying Paper Industry Co., LTD (“Anhui Shanying Paper”) in conjunction with its acquisition of Nordic Paper Holding AB (”Nordic Paper”) from Holding Blanc Bleu 5 S.à r.l, (controlled by funds which are advised by Orlando Management AG) and Petek GmbH.

Anhui Shanying Paper, which is part of the Taison Group, is a China-based pulp and papermill company which has been listed on the Shanghai stock exchange since 2001. Nordic Paper is a leading supplier of paper within the kraft paper and the greaseproof paper segments. Nordic Paper currently has four paper facilities in Bäckhammar, Åmotfors, Säffle in Sweden as well as Greåker in Norway and delivers paper to customers in more than 80 countries. The acquisition is conditional upon customary conditions to closing.

Vinge’s team has consisted of, among others, partners Jonas Bergström, Johan Larsson, senior counsel Gu Qun, associate Samra Baytar, counsel Joacim Rydergård, associates Pål Walhammar och Lisa Sennerby (M&A), counsel Johan Cederblad (Environmental), associates Lova Unge (Employment), Frida Ställborn (Real Estate), Josefine Lanker (Financial Arrangements), Victor Wahlqvist and Victor Berg (Commercial Agreements) and Parul Sharma (CSR and Compliance) and partner Pär Remnelid and associate Nils Alvång (EU, Competition & Regulatory)
 

Related

Vinge advises Trianon in connection with directed share issue and tender offer for subordinated sustainable capital securities

Vinge advises Fastighets Aktiebolaget Trianon (publ) in connection with a directed share issue of SEK 184 million and a tender offer for outstanding subordinated perpetual floating rate callable sustainable capital securities.
April 19, 2024

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024